−0.0904SEK
−95.51 MSEK
137.00 KSEK
958.67 M
About ABLIVA AB BTA
Sector
CEO
Ellen K. Donnelly
Headquarters
Lund
Website
Founded
2000
ISIN
SE0021921897
FIGI
BBG01LNW9P47
Abliva AB operates as a biopharmaceutical company, which engages in the research and development of medicines for the treatment of primary mitochondrial diseases. Its projects include KL1333 and NV354. The company was founded by Eskil Elmer on February 1, 2000 and is headquartered in Lund, Sweden.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of ABLI_BTA is 0.1650 SEK — it has decreased by 5.71% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OMXSTO exchange ABLIVA AB BTA stocks are traded under the ticker ABLI_BTA.
Yes, you can track ABLIVA AB BTA financials in yearly and quarterly reports right on TradingView.
ABLI_BTA stock has fallen by 28.26% compared to the previous week, the month change is a 28.26% fall, over the last year ABLIVA AB BTA has showed a 28.26% decrease.
ABLI_BTA net income for the last quarter is −25.24 M SEK, while the quarter before that showed −32.95 M SEK of net income which accounts for 23.42% change. Track more ABLIVA AB BTA financial stats to get the full picture.
Today ABLIVA AB BTA has the market capitalization of 175.14 M, it has increased by 3.89% over the last week.
No, ABLI_BTA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, ABLI_BTA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ABLIVA AB BTA stock right from TradingView charts — choose your broker and connect to your account.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ABLIVA AB BTA EBITDA is −87.47 M SEK, and current EBITDA margin is −63.84 K%. See more stats in ABLIVA AB BTA financial statements.